Cargando…
Inhibition of de novo pyrimidine synthesis augments Gemcitabine induced growth inhibition in an immunocompetent model of pancreatic cancer
Leflunomide (Lef) is an agent used in autoimmune disorders that interferes with DNA synthesis. De Novo pyrimidine synthesis is a mechanism of Gemcitabine (Gem) resistance in pancreatic cancer. This study aims to assess the efficacy and changes in the tumor microenvironment of Lef monotherapy and in...
Autores principales: | Phan, Thuy, Nguyen, Vu H., Buettner, Ralf, Morales, Corey, Yang, Lifeng, Wong, Paul, Tsai, Weiman, Salazar, Marcela d'Alincourt, Gil, Ziv, Diamond, Don J, Rabinowitz, Joshua D., Rosen, Steven, Melstrom, Laleh G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241727/ https://www.ncbi.nlm.nih.gov/pubmed/34239352 http://dx.doi.org/10.7150/ijbs.60473 |
Ejemplares similares
-
Inhibition of Autophagy Amplifies Baicalein-Induced Apoptosis in Human Colorectal Cancer
por: Phan, Thuy, et al.
Publicado: (2020) -
Leflunomide Synergizes with Gemcitabine in Growth Inhibition of PC Cells and Impairs c-Myc Signaling through PIM Kinase Targeting
por: Buettner, Ralf, et al.
Publicado: (2019) -
Salmonella-Mediated Therapy Targeting Indoleamine 2, 3-Dioxygenase 1 (IDO) Activates Innate Immunity and Mitigates Colorectal Cancer Growth
por: Phan, Thuy, et al.
Publicado: (2019) -
P38 kinase in gastrointestinal cancers
por: Phan, Thuy, et al.
Publicado: (2023) -
Drug screening identifies gemcitabine inhibiting rotavirus through alteration of pyrimidine nucleotide synthesis pathway
por: Chen, Sunrui, et al.
Publicado: (2020)